Treasure Valley Prostate Cancer Support

12/17/2025

Beyond the Diagnosis: Nurturing Your Mental, Physical & Emotional Well-being Through Prostate Cancer.

ZERO has a large library of educational webinars and videos touching on topics related to prostate cancer from treatment, side effects, research and more related to prostate cancer.

11/26/2025

Attached is a link that you can use to watch several videos from the patient conference on prostate cancer. Some subjects should be of interest.

Image Image Image Sixth Annual UCSF / California Prostate Cancer Coalition (CPCC) Patient Conference on Prostate Cancer Friday, April 17, 2026 (8:00AM-5:00PM, PT) UCSF Mission Bay Campus and live webcast Details will be posted here as they are available. Registration will open in 2026. Questions can...

11/26/2025

Bone health is very important and you should talk to your healthcare provider if you are on androgen depravation therapy. The standby treatments are Xgeva, Prolia, or zoledronic acid. Another drug, a biosimilar from Sandoz, has entered the field - Wyost or Jubbonth.

Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz), the first and only FDA-approved denosumab biosimilars, to treat all indications of the reference medicines.

11/26/2025

Prostate Cancer Foundation is the largest independent source of prostate cancer research funds. More recently, they have also added videos like this addressing information for patients and loved ones.

View Transcript here. Dr. Oliver Sartor provides an overview of advanced prostate cancer and describes significant improvements in diagnosis and treatment

09/17/2025

I've had "posts" about this or that, but here is a link to materials at ZERO Prostate Cancer that gives links to their prostate cancer information for all stages and for caregivers. Scroll through it. There is information from when to test, what to look for, what questions to ask, early and advanced. [One comment: you will see that NCCN after age 75 does not recommend PSA test - THAT'S ONLY IF YOU'VE BEEN TESTING, following the guidelines, up until then. If you have not been tested - get tested!]

Prostate cancer brochures, pamphlets, and fact sheets, free for you to download or request by mail. Educational materials are categorized by prostate cancer stages, specific topics, audiences and interest categories, and more. We add new documents on a regular basis.

07/24/2025

Who knew that you might live longer with healthy living? [Probably all of us, but here are some numbers from PCF.]
From the Research Desk: Healthier Lifestyle Linked to Longer Life After Diagnosis

Need another reason to lace up your walking shoes? More research suggests that leading a healthier lifestyle after being diagnosed with prostate cancer substantially lowered a person’s risk of dying from any cause.

Leading a healthier lifestyle after being diagnosed with non-metastatic prostate cancer was linked to a more than 30% decrease in risk of dying from any

07/19/2025

Here is a link to an article from PCF (Prostate Cancer Foundation), a very trusted site. It deals frankly with the issues of sexual intimacy that arise with prostate cancer.

This article shares options and insights for men and couples seeking to strengthen physical intimacy after prostate cancer treatment. Therefore, it

06/10/2025

For those of us facing metastatic castrate resistant prostate cancer you might find value in this magazine. It seems to include an inordinate number of advertisements for Pluvicto, but you're going to want to be informed about this drug regimen anyway.

04/21/2025

For a while, it was believed that it was safer to not be screened for prostate cancer than to be screened. [Personal opinion: it was never the over diagnosis that was/is the problem - the problem comes from over treatment.] Here is a study that shows skipping screening (and thus diagnosis) results in 45% higher mortality (=DEATH) from prostate cancer. [I know that the picture says 23%, but go to the link and read the article, it's 45%.]

Men who avoided prostate cancer screening were significantly more likely to die from the disease, according to a large European trial. The reasons for ignoring prostate cancer screening are complex but may be related to a lack of education about the importance of the diagnostic procedure.

04/13/2025

Here is a link to the new "Prostate Policy Pulse", the "Pulse". It comes from the Government Relations & Advocacy offices of ZERO Prostate Cancer (ZeroCancer.org). They will break down what is happening in the government with respect to prostate cancer and what it means for our prostate cancer community and what we can do about it, together.
https://zerocancer.quorum.us/prostatepulse/

03/30/2025

Prostate Cancer Foundation (PCF) is huge in the world of private organizations funding prostate cancer research. They are also extremely good with patient guides and patient information. This link takes you to the first of several informative articles with links at the bottom of each to the next. GOOD READS!

Many studies have shown that hitting prostate cancer hard in early metastasis with more than one treatment approach minimizes symptoms, preserves quality of life, and prolongs survival.  So why aren’t more men being offered the standard of care? What is undertreatment?  It’s aiming too low: un...

03/30/2025

Great news! Pluvicto, the radioligand treatment also called Lutetium 177 has been approved by the FDA for use without the requirement for chemotherapy first. Now men with advanced and advancing prostate cancer can use Pluvicto (presuming it is appropriate) BEFORE chemotherapy. This provides another option for treatment at that stage in advanced prostate cancer. [I do not know when private insurance and/or Medicare will approve coverage, but hopefully not long.]
https://www.pcf.org/c/breaking-news-expanded-fda-approval-of-177lutetium-psma-617/

, ,

What this means for patients: Today, the therapy 177lutetium-PSMA-617 (Lu-PSMA; trade name Pluvicto®) was approved by the FDA for patients with advanced (metastatic) prostate cancer who have been treated with androgen receptor pathway inhibitor therapy. This medicine delivers a small dose of rad...